NCT02221440View on ClinicalTrials.gov

Maternal Oxygen Administration for Fetal Distress

NACompletedINTERVENTIONAL
Enrollment

443

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Oxygen Inhalation TherapySecond Stage of LabourFetal Distress
Interventions
DEVICE

Low flow nasal oxygen

Oxygen will be administered by nasal catheter at a flow rate of 2 L/min. The therapy will continue until after delivery

DEVICE

Low flow room air

Sham: oxygen will be administered by nasal catheter at a flow rate of 0 L/min.

Trial Locations (3)

100048

Department of Obstetrics and Gynecology, Navy General Hospital., Beijing

Navy General Hospital, Beijing

Department of Obstetrics and Gynecology, Navy General Hospital., Beijing

All Listed Sponsors
lead

Navy General Hospital, Beijing

OTHER

NCT02221440 - Maternal Oxygen Administration for Fetal Distress | Biotech Hunter | Biotech Hunter